The Trump administration has made some concessions to the halt placed on distributions of global HIV treatments via the U.S.

The State Department issued a waiver for lifesaving aid, but HIV clinics remain shut and uncertainty lingers over the future ...

A stop in all of PEPFAR’s work shuttered clinics this week. Then, a new exemption for “life-saving” treatment left ...

The current U.S. government, under the leadership of Donald Trump, has decided to freeze funding for the President’s ...

So far, the FDA has approved the drug only for people who already have HIV that’s resistant to other treatments. But its ...

The United States Secretary of State, Marco Rubio, has approved an “Emergency Humanitarian Waiver” to ensure continued access ...

Gilead Sciences, Inc. (NASDAQ:GILD), a leading biopharmaceutical company with a market capitalization of $119.32 billion, has been making significant strides in its core HIV franchise while expanding ...

The HIV epidemic continues to disproportionately affect major urban centers across the United States, with southern cities ...

The Trump administration's aid freeze affects HIV treatment access. Find out how organizations are coping with the directive.

As a result of the new administration's actions, health centers funded by PEPFAR, the U.S. President's Emergency Plan for ...

A move by the Trump administration to freeze funding for PEPFAR, the widely heralded international HIV/AIDS program, is ...

The WHO said funding should be maintained for programmes like PEPFAR, which provides HIV treatment and testing to millions of ...